← All Sponsors
SPONSOR

Neurona Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Epilepsy, Temporal Lobe
NCT06422923 Phase 1, Phase 2
Recruiting

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Epilepsy, Temporal Lobe
United States View Trial →